Selected data models

You must log in to select data models for download or further analysis.

73 Search results.
Relevance Rating New first Old first

LASER ADMINISTRATION FELLOW EYE (UNSCHEDULED) CRFs Roche FVF4170G Macular Edema NCT00473382

- 6/28/17 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Patient administration, LASER ADMINISTRATION STUDY EYE
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 36) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 36)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 35) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 35)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 34) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 34)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 33) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 33)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 32) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 32)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 21) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 21)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 22) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 22)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 19) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 19)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 23) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 23)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 20) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 20)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 24) CRFs Roche FVF4170G Macular Edema NCT-Nummer NCT00473382

- 7/27/17 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Patient administration, RESCUE LASER ADMINISTRATION AND CRITERIA STUDY EYE (MONTH 24)
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial